Gossamer Bio's Seralutinib shows promise for PAH and PH-ILD treatment. The main event comes with its topline results in Q4 ...
However, the function and mechanism of IL-11 in these diseases remain unknown ... Multiple molecular pathways work together to drive vasoconstriction, pulmonary artery remodeling, and progressive ...
The 3 major pathways (endothelin-1, nitric oxide, and prostacyclin) involved in the regulation of pulmonary vasomotor tone are shown ... which promotes vasoconstriction and smooth muscle cell ...
A discovery offers new hope in the battle against pulmonary fibrosis, a debilitating lung condition that progressively makes it harder for patients to breathe. Scientists have pinpointed proteins in ...
A discovery at Duke-NUS Medical School offers new hope in the battle against pulmonary fibrosis, a debilitating lung ...
Northwestern Medicine investigators have discovered new mechanisms underlying cellular adhesion and repair, findings that ...
titled "Acquired RUFY1-RET rearrangement as a mechanism of resistance to lorlatinib in a patient with CD74-ROS1 rearranged non-small cell lung cancer: A case report." In this case report ...
LAS VEGAS, NV, UNITED STATES, February 13, 2025 /EINPresswire / -- DelveInsight's,“Pulmonary Arterial Hypertension ... a different mechanism of action, and molecular type. . Detailed analysis ...